<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-MedLine.d164"> 
   <sentence id="DDI-MedLine.d164.s0" text="Lapatinib enhances herceptin-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression.
" new_text="Lapatinib@@enhances@@herceptin@@-mediated@@antibody-dependent@@cellular@@cytotoxicity@@by@@up-regulation@@of@@cell@@surface@@HER2@@expression@@.@@"> 
      <entity id="DDI-MedLine.d164.s0.e0" charOffset="0-8" type="drug" text="Lapatinib" position="0"/>  
      <entity id="DDI-MedLine.d164.s0.e1" charOffset="19-27" type="brand" text="herceptin" position="2"/>  
      <pair id="DDI-MedLine.d164.s0.p0" e1="DDI-MedLine.d164.s0.e0" e2="DDI-MedLine.d164.s0.e1" ddi="true" type="effect" flags="True" e1_name="Lapatinib" e2_name="herceptin" e1_pos="0" e2_pos="2" path="0@@1@@6@@2@@">Lapatinib@@@@nsubj@@enhances@@dobj@@cytotoxicity@@nn@@herceptin</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d164.s1" text="Although it was previously reported that lapatinib combined with Herceptin improved the progression-free survival rate compared with lapatinib alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents." new_text="Although@@it@@was@@previously@@reported@@that@@lapatinib@@combined@@with@@Herceptin@@improved@@the@@progression-free@@survival@@rate@@compared@@with@@lapatinib@@alone@@for@@patients@@with@@Herceptin@@-refractory@@HER2-positive@@metastatic@@breast@@cancer@@,@@the@@mechanism@@is@@purported@@to@@be@@an@@antiproliferative@@effect@@relating@@to@@the@@synergism@@of@@these@@two@@agents@@.@@"> 
      <entity id="DDI-MedLine.d164.s1.e0" charOffset="41-49" type="drug" text="lapatinib" position="6"/>  
      <entity id="DDI-MedLine.d164.s1.e1" charOffset="65-73" type="brand" text="Herceptin" position="9"/>  
      <entity id="DDI-MedLine.d164.s1.e2" charOffset="133-141" type="drug" text="lapatinib" position="17"/>  
      <entity id="DDI-MedLine.d164.s1.e3" charOffset="167-175" type="brand" text="Herceptin" position="22"/>  
      <pair id="DDI-MedLine.d164.s1.p0" e1="DDI-MedLine.d164.s1.e0" e2="DDI-MedLine.d164.s1.e1" ddi="true" type="effect" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="6" e2_pos="9" path="6@@7@@8@@9@@">lapatinib@@@@prep@@combined@@pcomp@@with@@pobj@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s1.p1" e1="DDI-MedLine.d164.s1.e0" e2="DDI-MedLine.d164.s1.e2" ddi="false" flags="True" e1_name="lapatinib" e2_name="lapatinib" e1_pos="6" e2_pos="17" path="6@@10@@17@@">lapatinib@@@@nsubj@@improved@@pobj@@lapatinib</pair>  
      <pair id="DDI-MedLine.d164.s1.p2" e1="DDI-MedLine.d164.s1.e0" e2="DDI-MedLine.d164.s1.e3" ddi="false" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="6" e2_pos="22" path="6@@10@@17@@20@@27@@22@@">lapatinib@@@@nsubj@@improved@@pobj@@lapatinib@@prep_for@@patients@@prep_with@@cancer@@nn@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s1.p3" e1="DDI-MedLine.d164.s1.e1" e2="DDI-MedLine.d164.s1.e2" ddi="false" flags="True" e1_name="Herceptin" e2_name="lapatinib" e1_pos="9" e2_pos="17" path="9@@8@@7@@6@@10@@17@@">Herceptin@@@@pobj@@with@@pcomp@@combined@@prep@@lapatinib@@nsubj@@improved@@pobj@@lapatinib</pair>  
      <pair id="DDI-MedLine.d164.s1.p4" e1="DDI-MedLine.d164.s1.e1" e2="DDI-MedLine.d164.s1.e3" ddi="false" flags="True" e1_name="Herceptin" e2_name="Herceptin" e1_pos="9" e2_pos="22" path="9@@8@@7@@6@@10@@17@@20@@27@@22@@">Herceptin@@@@pobj@@with@@pcomp@@combined@@prep@@lapatinib@@nsubj@@improved@@pobj@@lapatinib@@prep_for@@patients@@prep_with@@cancer@@nn@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s1.p5" e1="DDI-MedLine.d164.s1.e2" e2="DDI-MedLine.d164.s1.e3" ddi="false" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="17" e2_pos="22" path="17@@20@@27@@22@@">lapatinib@@@@prep_for@@patients@@prep_with@@cancer@@nn@@Herceptin</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d164.s2" text="We evaluated how lapatinib interacts with Herceptin in HER2-positive breast cancer, with a particular focus on Herceptin-mediated antibody-dependent cellular cytotoxicity (ADCC). " new_text="We@@evaluated@@how@@lapatinib@@interacts@@with@@Herceptin@@in@@HER2-positive@@breast@@cancer@@,@@with@@a@@particular@@focus@@on@@Herceptin@@-mediated@@antibody-dependent@@cellular@@cytotoxicity@@(ADCC)@@.@@"> 
      <entity id="DDI-MedLine.d164.s2.e0" charOffset="17-25" type="drug" text="lapatinib" position="3"/>  
      <entity id="DDI-MedLine.d164.s2.e1" charOffset="42-50" type="brand" text="Herceptin" position="6"/>  
      <entity id="DDI-MedLine.d164.s2.e2" charOffset="111-119" type="brand" text="Herceptin" position="17"/>  
      <pair id="DDI-MedLine.d164.s2.p0" e1="DDI-MedLine.d164.s2.e0" e2="DDI-MedLine.d164.s2.e1" ddi="false" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="3" e2_pos="6" path="3@@4@@6@@">lapatinib@@@@nsubj@@interacts@@prep_with@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s2.p1" e1="DDI-MedLine.d164.s2.e0" e2="DDI-MedLine.d164.s2.e2" ddi="false" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="3" e2_pos="17" path="3@@4@@15@@22@@17@@">lapatinib@@@@nsubj@@interacts@@prep_with@@focus@@prep_on@@(ADCC)@@nn@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s2.p2" e1="DDI-MedLine.d164.s2.e1" e2="DDI-MedLine.d164.s2.e2" ddi="false" flags="True" e1_name="Herceptin" e2_name="Herceptin" e1_pos="6" e2_pos="17" path="6@@4@@15@@22@@17@@">Herceptin@@@@prep_with@@interacts@@prep_with@@focus@@prep_on@@(ADCC)@@nn@@Herceptin</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d164.s3" text="In an in vitro assay, lapatinib induced HER2 expression at the cell surface of HER2-positive breast cancer cell lines, leading to the enhancement of Herceptin-mediated ADCC. " new_text="In@@an@@in@@vitro@@assay@@,@@lapatinib@@induced@@HER2@@expression@@at@@the@@cell@@surface@@of@@HER2-positive@@breast@@cancer@@cell@@lines@@,@@leading@@to@@the@@enhancement@@of@@Herceptin@@-mediated@@ADCC@@.@@"> 
      <entity id="DDI-MedLine.d164.s3.e0" charOffset="22-30" type="drug" text="lapatinib" position="6"/>  
      <entity id="DDI-MedLine.d164.s3.e1" charOffset="149-157" type="brand" text="Herceptin" position="26"/>  
      <pair id="DDI-MedLine.d164.s3.p0" e1="DDI-MedLine.d164.s3.e0" e2="DDI-MedLine.d164.s3.e1" ddi="true" type="effect" flags="True" e1_name="lapatinib" e2_name="Herceptin" e1_pos="6" e2_pos="26" path="6@@7@@13@@28@@21@@24@@26@@">lapatinib@@@@nsubj@@induced@@prep_at@@surface@@prep_of@@ADCC@@amod@@leading@@prep_to@@enhancement@@prep_of@@Herceptin</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d164.s4" text="Furthermore, we present a case report in which a second Herceptin treatment following lapatinib resulted in the marked shrinkage of multiple metastatic tumors in HER2-positive breast cancer. " new_text="Furthermore@@,@@we@@present@@a@@case@@report@@in@@which@@a@@second@@Herceptin@@treatment@@following@@lapatinib@@resulted@@in@@the@@marked@@shrinkage@@of@@multiple@@metastatic@@tumors@@in@@HER2-positive@@breast@@cancer@@.@@"> 
      <entity id="DDI-MedLine.d164.s4.e0" charOffset="56-64" type="brand" text="Herceptin" position="11"/>  
      <entity id="DDI-MedLine.d164.s4.e1" charOffset="86-94" type="drug" text="lapatinib" position="14"/>  
      <pair id="DDI-MedLine.d164.s4.p0" e1="DDI-MedLine.d164.s4.e0" e2="DDI-MedLine.d164.s4.e1" ddi="true" type="effect" flags="True" e1_name="Herceptin" e2_name="lapatinib" e1_pos="11" e2_pos="14" path="11@@12@@14@@">Herceptin@@@@nn@@treatment@@prep_following@@lapatinib</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d164.s5" text="Lapatinib may have the potential to convert Herceptin-refractory to Herceptin-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2." new_text="Lapatinib@@may@@have@@the@@potential@@to@@convert@@Herceptin@@-refractory@@to@@Herceptin@@-sensitive@@tumors@@in@@HER2-positive@@breast@@cancer@@by@@up-regulation@@of@@the@@cell@@surface@@expression@@of@@HER2@@.@@"> 
      <entity id="DDI-MedLine.d164.s5.e0" charOffset="0-8" type="drug" text="Lapatinib" position="0"/>  
      <entity id="DDI-MedLine.d164.s5.e1" charOffset="44-52" type="brand" text="Herceptin" position="7"/>  
      <entity id="DDI-MedLine.d164.s5.e2" charOffset="68-76" type="brand" text="Herceptin" position="10"/>  
      <pair id="DDI-MedLine.d164.s5.p0" e1="DDI-MedLine.d164.s5.e0" e2="DDI-MedLine.d164.s5.e1" ddi="false" flags="True" e1_name="Lapatinib" e2_name="Herceptin" e1_pos="0" e2_pos="7" path="0@@2@@4@@6@@8@@7@@">Lapatinib@@@@nsubj@@have@@dobj@@potential@@infmod@@convert@@dobj@@-refractory@@amod@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s5.p1" e1="DDI-MedLine.d164.s5.e0" e2="DDI-MedLine.d164.s5.e2" ddi="false" flags="True" e1_name="Lapatinib" e2_name="Herceptin" e1_pos="0" e2_pos="10" path="0@@2@@4@@6@@12@@10@@">Lapatinib@@@@nsubj@@have@@dobj@@potential@@infmod@@convert@@prep_to@@tumors@@amod@@Herceptin</pair>  
      <pair id="DDI-MedLine.d164.s5.p2" e1="DDI-MedLine.d164.s5.e1" e2="DDI-MedLine.d164.s5.e2" ddi="false" flags="True" e1_name="Herceptin" e2_name="Herceptin" e1_pos="7" e2_pos="10" path="7@@8@@6@@12@@10@@">Herceptin@@@@amod@@-refractory@@dobj@@convert@@prep_to@@tumors@@amod@@Herceptin</pair> 
   </sentence> 
</document>
